Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers

Kenneth R Chapman; Nils Ringdal; Vibeke Backer; Mona Palmqvist; Seppo Saarelainen; Mark Briggs

doi:10.1155/1999/894803

Canadian Respiratory Journal (Jan 1999)

Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers

Kenneth R Chapman,
Nils Ringdal,
Vibeke Backer,
Mona Palmqvist,
Seppo Saarelainen,
Mark Briggs

Affiliations

Kenneth R Chapman: Toronto Hospital (Western Division), Toronto, Ontario, Canada
Nils Ringdal: Molde Hospital, Molde, Norway
Vibeke Backer: Department of Internal Medicine, Lung Division, Bispebjerg Hospital, Copenhagen, Denmark
Mona Palmqvist: Asthma and Allergy Centre, Sahlgrenska University Hospital, Gothenberg, Sweden
Seppo Saarelainen: Tampere University Hospital, Pikonlinna Hospital, Pikonlinna, Finland
Mark Briggs: Respiratory Clinical Research, GlaxoWellcome Research and Development, Greenford, Middlesex, UK

DOI: https://doi.org/10.1155/1999/894803
Journal volume & issue: Vol. 6, no. 1
pp. 45 – 51

Abstract

Read online

OBJECTIVE: To compare the efficacy and safety of a new combination Diskus inhaler containing both salmeterol 50 μg and fluticasone propionate 250 μg (Seretide) with the two drugs delivered via separate Diskus inhalers.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://www.hindawi.com/journals/crj/

About the journal